148 related articles for article (PubMed ID: 37882056)
1. FDG PET/CT in a Case of Thoracic SMARCA4-Deficient Undifferentiated Tumor.
Guo J; Liao Z; Chen Q; Dong A; Huang M
Clin Nucl Med; 2023 Dec; 48(12):1111-1113. PubMed ID: 37882056
[TBL] [Abstract][Full Text] [Related]
2. Superior Identification of Metastatic Lesions by 68 Ga-FAPI-46 to 18 F-FDG PET/CT in a Case of SMARCA4-Deficient Undifferentiated Carcinoma of Stomach.
Pang Y; Cai J; Zhao L; Xu W; Chen H
Clin Nucl Med; 2023 Nov; 48(11):1009-1011. PubMed ID: 37703493
[TBL] [Abstract][Full Text] [Related]
3. 68 Ga-DOTA-FAPI-04 PET/CT in the Detection of Thoracic SMARCA4-Deficient Undifferentiated Tumor.
Shen X; Yang Z; Li N
Clin Nucl Med; 2023 Dec; 48(12):1102-1104. PubMed ID: 37846457
[TBL] [Abstract][Full Text] [Related]
4. Imaging features of SMARCA4-deficient thoracic sarcomas: a multi-centric study of 21 patients.
Crombé A; Alberti N; Villard N; Pilleul F; Buy X; Le Loarer F; Kind M
Eur Radiol; 2019 Sep; 29(9):4730-4741. PubMed ID: 30762113
[TBL] [Abstract][Full Text] [Related]
5. [Thoracic SMARCA4-deficient undifferentiated tumor resembling malignant lymphoma].
Asou C; Maeda T; Yamaguchi O; Okamura D; Ishikawa M; Kohri M; Tsukasaki K; Matsuda A; Asou N; Satoh T; Kayano H; Takahashi N
Rinsho Ketsueki; 2023; 64(4):271-276. PubMed ID: 37121771
[TBL] [Abstract][Full Text] [Related]
6. SMARCA4-deficient thoracic tumor detected by [
Okazaki T; Yokoyama K; Tsuchiya J; Honda T; Ishikawa Y; Kirimura S; Miyazaki Y; Tateishi U
Eur J Hybrid Imaging; 2021 Apr; 5(1):8. PubMed ID: 34181162
[TBL] [Abstract][Full Text] [Related]
7. SMARCA4-deficient undifferentiated tumor that responded to chemotherapy in combination with immune checkpoint inhibitors: A case report.
Utsumi T; Taniguchi Y; Noda Y; Fukai M; Kibata K; Murakawa T
Thorac Cancer; 2022 Aug; 13(15):2264-2266. PubMed ID: 35778998
[TBL] [Abstract][Full Text] [Related]
8.
Nakra T; Kakkar A; Mathur SR; Jain D; Kumar S
Int J Surg Pathol; 2023 Feb; 31(1):104-109. PubMed ID: 35466749
[No Abstract] [Full Text] [Related]
9. SMARCA4-deficient tumors in the adrenal gland and small intestines: A rare case report.
Kambe A; Yamamoto Y; Hasegawa C; Kakiuchi A; Kojima D; Hino A; Horikawa A; Doiuchi T; Kurihara H
Radiol Case Rep; 2024 Feb; 19(2):794-797. PubMed ID: 38111549
[TBL] [Abstract][Full Text] [Related]
10. SMARCA4-deficient thoracic sarcoma: a distinctive clinicopathological entity with undifferentiated rhabdoid morphology and aggressive behavior.
Sauter JL; Graham RP; Larsen BT; Jenkins SM; Roden AC; Boland JM
Mod Pathol; 2017 Oct; 30(10):1422-1432. PubMed ID: 28643792
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological and molecular characterization of SMARCA4-deficient thoracic sarcomas with comparison to potentially related entities.
Yoshida A; Kobayashi E; Kubo T; Kodaira M; Motoi T; Motoi N; Yonemori K; Ohe Y; Watanabe SI; Kawai A; Kohno T; Kishimoto H; Ichikawa H; Hiraoka N
Mod Pathol; 2017 Jun; 30(6):797-809. PubMed ID: 28256572
[TBL] [Abstract][Full Text] [Related]
12. (68)Ga-DOTA-peptide: A novel molecular biomarker for nasopharyngeal carcinoma.
Khor LK; Loi HY; Sinha AK; Tong KT; Goh BC; Loh KS; Lu SJ
Head Neck; 2016 Apr; 38(4):E76-80. PubMed ID: 26275126
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of cell block examination for the cytological diagnosis of thoracic SMARCA4-deficient undifferentiated tumor: A case report.
Minoshima A; Sugita S; Segawa K; Aoyama T; Ito M; Daimon F; Takenami T; Kido T; Moriya J; Nishikiori H; Hasegawa T
Diagn Cytopathol; 2023 May; 51(5):E149-E154. PubMed ID: 36772934
[TBL] [Abstract][Full Text] [Related]
14. SMARCA4-Deficient Thoracic Sarcoma: A Case Report and Review of Literature.
Stewart BD; Kaye F; Machuca T; Mehta HJ; Mohammed TL; Newsom KJ; Starostik P
Int J Surg Pathol; 2020 Feb; 28(1):102-108. PubMed ID: 31382829
[TBL] [Abstract][Full Text] [Related]
15. Cytopathological Features of
Takeda M; Tani Y; Saijo N; Shimizu S; Taniguchi Y; Otsuka K; Nakao K; Tamiya A; Okishio K; Atagi S; Ohbayashi C; Kasai T
Int J Surg Pathol; 2020 Feb; 28(1):109-114. PubMed ID: 31448657
[No Abstract] [Full Text] [Related]
16. Thorahcic SMARCA4-deficient undifferentiated tumors with ganglioneuroma and enchondroma: implications for SLC7A11 and ARID1A expression: a case report.
Kito Y; Kawashima K; Saigo C; Hasegawa M; Nomura S; Mikamo T; Hanamatsu Y; Matsuo Y; Takeuchi T
Diagn Pathol; 2022 Feb; 17(1):29. PubMed ID: 35151345
[TBL] [Abstract][Full Text] [Related]
17. Cytology of SMARCA4-Deficient Thoracic Neoplasms: Comparative Analysis of SMARCA4-Deficient Non-Small Cell Lung Carcinomas and SMARCA4-Deficient Thoracic Sarcomas.
Nambirajan A; Dutta R; Malik PS; Bubendorf L; Jain D
Acta Cytol; 2021; 65(1):67-74. PubMed ID: 32854100
[TBL] [Abstract][Full Text] [Related]
18. Exceptionally rapid response to pembrolizumab in a SMARCA4-deficient thoracic sarcoma overexpressing PD-L1: A case report.
Takada K; Sugita S; Murase K; Kikuchi T; Oomori G; Ito R; Hayasaka N; Miyanishi K; Iyama S; Ikeda H; Kobune M; Emori M; Kato J; Hasegawa T
Thorac Cancer; 2019 Dec; 10(12):2312-2315. PubMed ID: 31617320
[TBL] [Abstract][Full Text] [Related]
19. FDG PET/CT in a Case With Cellular Schwannoma of the Kidney.
Yu Z; Zhang J; Dong A; Zhu Y
Clin Nucl Med; 2022 Nov; 47(11):996-997. PubMed ID: 35619199
[TBL] [Abstract][Full Text] [Related]
20. Infrequent loss of SMARCA4, SMARCA2, and SMARCB1 expression in uterine mesenchymal tumors.
Kihara A; Amano Y; Matsubara D; Fukushima N; Fujiwara H; Niki T
Hum Pathol; 2021 Oct; 116():12-21. PubMed ID: 34271067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]